YouGov polling commissioned by PSNC has shown the strength of public support for pharmacies and for a Pharmacy First service. The results show the extent of the public backing for a Pharmacy First approach – PSNC has been arguing that a fully-funded service would be beneficial for pharmacies, patients and the wider NHS. And they [...]
The post Public overwhelmingly back Pharmacy First appeared first on PSNC Website.
Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) Drug alert number: EL (23)A/13 Date issued: 30 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Briviact 75 mg film-coated tablets, PLPI 18716/0146 SNOMED Code: 37622711000001100 Batch number Expiry date [...]
The post MHRA Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has today (30/03/2023) granted the following list of price concessions for March 2023. Drug Pack size Price concession Bicalutamide 150mg tablets 28 £3.96 Cefalexin 250mg tablets 28 £2.86 Cefalexin 500mg capsules 21 £2.80 Cefalexin 500mg tablets 21 £2.80 Cinnarizine 15mg tablets 84 £5.70 Clarithromycin 125mg/5ml oral suspension 70 [...]
The post March 2023 Price Concessions 3rd Update appeared first on PSNC Website.
Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 25 new products were classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 April 2023. This took the total number of products granted DND status to over 600 products following checks [...]
The post 25 products added to the Discount Not Deducted (DND) list from April 2023 appeared first on PSNC Website.
Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of Colesevelam 625mg tablets. From April 2023, the listing in Part VIII of the Drug Tariff has been updated to reflect the change in special container status as it meets the relevant criteria as set out in Part [...]
The post Colesevelam 625mg tablets reclassified as a special container appeared first on PSNC Website.
Recent Comments